Liver transplantation in septuagenarians receiving model for end-stage liver disease exception points for hepatocellular carcinoma: The national experience

被引：7
|
作者：
Schwartz, Jason [1 ]
Thiesset, Heather [2 ]
Box, Terry [3 ]
Hutson, William [4 ]
Sorensen, John [2 ]
机构：
[1] Univ Texas SW Med Ctr Dallas, Div Surg Transplantat, Dept Surg, Dallas, TX 75390 USA
[2] Univ Utah, Dept Gen Surg, Sect Transplantat, Salt Lake City, UT USA
[3] Univ Utah, Dept Med, Salt Lake City, UT USA
[4] Univ Maryland, Sch Med, Div Gastroenterol & Hepatol, Baltimore, MD 21201 USA
来源：
LIVER TRANSPLANTATION | 2012年 / 18卷 / 11期
关键词：
D O I：
10.1002/lt.23513
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1395 / 1396
页数：2
相关论文
共 50 条
  • [31] Mind the Model for End-Stage Liver Disease: Model for End-Stage Liver Disease Score as an Indicator of Hemoderivate Transfusion and Survival in Liver Transplantation
    Alonso, I. J.
    Maestro, O. C.
    Gomez, N. F.
    Mateos, R. S.
    Quinto, A. M.
    Molero, F. C.
    Municio, A. M.
    Pulido, J. C.
    Segurola, C. L.
    Romero, C. J.
    TRANSPLANTATION PROCEEDINGS, 2015, 47 (01) : 97 - 99
  • [32] Liver transplantation for end-stage alcoholic liver disease: An Italian experience.
    Biselli, M
    Gramenzi, A
    Grazi, GL
    Cursaro, C
    Di Giammarino, L
    Felline, F
    Stefanini, GF
    Iovine, E
    Mazziotti, A
    Cavallari, A
    Andreone, P
    Bernardi, M
    HEPATOLOGY, 1999, 30 (04) : 182A - 182A
  • [33] Outcomes of liver transplantation for hepatocellular carcinoma in septuagenarians
    Najjar, M.
    Bruestle, K.
    Jiang, P.
    Nattakom, M.
    Hwang, R.
    Mathur, A.
    Verna, E.
    Griesemer, A.
    Samstein, B.
    Kato, T.
    Saenger, Y.
    Halazun, K.
    Emond, J.
    TRANSPLANTATION, 2019, 103 (08) : 318 - 318
  • [34] Outcomes of Liver Transplantation for Hepatocellular Carcinoma in Septuagenarians
    Najjar, M.
    Bruestle, K.
    Jiang, P.
    Lieberman, E.
    Hwang, R.
    Mathur, A.
    Verna, E. C.
    Griesemer, A.
    Samstein, B.
    Kato, T.
    Saenger, Y. M.
    Halazun, K. J.
    Emond, J. C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 1072 - 1073
  • [35] MELDEQ: An Alternative Model for End-Stage Liver Disease Score for Patients With Hepatocellular Carcinoma
    Marvin, Michael R.
    Ferguson, Nicole
    Cannon, Robert M.
    Jones, Christopher M.
    Brock, Guy N.
    LIVER TRANSPLANTATION, 2015, 21 (05) : 612 - 622
  • [36] Model for end-stage liver disease score predicts survival in patients with hepatocellular carcinoma
    Contreras, C. M.
    Behrens, J.
    Cho, C. S.
    Mahvi, D. M.
    Rikkers, L. F.
    Weber, S. M.
    ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (02) : 96 - 96
  • [37] Could tenofovir modify the model end-stage liver disease (MELD) score in patients with end-stage liver disease eligible for liver transplantation?
    Bruno, Raffaele
    Sacchi, Paolo
    Filice, Gaetano
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2007, 45 (01) : 123 - 123
  • [38] Liver Transplantation in Recipients With High Model for End-stage Liver Disease Score
    Gonzalez Martinez, S.
    Molina Raya, A.
    Becerra Massare, A.
    Muffak Granero, K.
    Villegas Herrera, T.
    Villar del Moral, J. M.
    Fundora Suarez, Y.
    TRANSPLANTATION PROCEEDINGS, 2018, 50 (02) : 595 - 597
  • [39] Outcomes of liver transplantation for end-stage biliary disease: A comparative study with end-stage liver disease
    Yan-Hua Lai
    Wei-Dong Duan
    Qiang Yu
    Sheng Ye
    Nian-Jun Xiao
    Dong-Xin Zhang
    Zhi-Qiang Huang
    Zhan-Yu Yang
    Jia-Hong Dong
    World Journal of Gastroenterology, 2015, (20) : 6296 - 6303
  • [40] Stem cell therapy for hepatocellular carcinoma and end-stage liver disease
    Abdellateif, Mona S.
    Zekri, Abdel-Rahman N.
    JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE, 2023, 35 (01)
12345